Cargando…
Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity
BACKGROUND: Immune checkpoint blockade has emerged as a potential cancer immunotherapy. The “don’t eat me” signal CD47 in cancer cells binds signal regulatory protein-α on macrophages and prevents their phagocytosis. The role of miR-340 in pancreatic ductal adenocarcinoma (PDAC), especially in tumor...
Autores principales: | Xi, Qing, Zhang, Jieyou, Yang, Guangze, Zhang, Lijuan, Chen, Ying, Wang, Chengzhi, Zhang, Zimu, Guo, Xiangdong, Zhao, Jingyi, Xue, Zhenyi, Li, Yan, Zhang, Qi, Da, Yurong, Liu, Li, Yao, Zhi, Zhang, Rongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279671/ https://www.ncbi.nlm.nih.gov/pubmed/32503944 http://dx.doi.org/10.1136/jitc-2019-000253 |
Ejemplares similares
-
Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization
por: Zhang, Lijuan, et al.
Publicado: (2021) -
Arctigenin protects mice from thioglycollate‐induced acute peritonitis
por: Zhao, Jingyi, et al.
Publicado: (2020) -
miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock
por: Xue, Zhenyi, et al.
Publicado: (2019) -
Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity
por: Qu, Tailong, et al.
Publicado: (2022) -
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response
por: Stirling, Elizabeth R, et al.
Publicado: (2022)